Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy: Difference between revisions
Jump to navigation
Jump to search
m (table) |
m (KOSM) |
||
| Line 26: | Line 26: | ||
|slow release | |slow release | ||
|- style="vertical-align:top; background:#ffffff;" | |- style="vertical-align:top; background:#ffffff;" | ||
|align="left" style="background:#99ff99"|''' | |align="left" style="background:#99ff99"|'''[[carbamazepine]]''' |||[[normal]] | ||
|xr | |xr | ||
|- style="vertical-align:top; background:#ffffff;" | |- style="vertical-align:top; background:#ffffff;" | ||
Revision as of 17:08, 25 July 2015
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO states 50 millions persons affect by epilepsy[2]
nonadherence appears to be associated with increased health care costs,nevertheless XR-medicine appears as strategy to overcome compliance AED [3]
|
Medicines | ||||
| type | ,,, | ,,,, | ||
| INN | Generic | slow release | ||
| carbamazepine | normal | xr | ||
| lamotrigine | normal | xr | ||
| levetiracetam | normal | xr | ||
| oxcarbazepine | ... | xr | ||
| phenitoin | ... | xr | ||
| valproate | xr | |||
| topiramat | xr | |||
|
AED | ||||
ILAE Classification
[4] [5] A new perspective for Epileptic Disorders
Links
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Dravet's syndrome
| References: |
|